A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding

Steven Hunt, Lily L. Wu, Barry M. Stults, Roger R. Williams

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To investigate what effects a circulating digoxin-like factor (DLF) might have on sodium metabolism, we examined data collected on 1,327 individuals screened in the Cardiovascular Genetics Clinic at the University of Utah. This sample included 639 unmedicated adults, 582 youths under age 18, and 106 medicated hypertensive individuals, all on an unrestricted diet when attending clinic. No individuals took digitalis. A digoxin assay detected measurable levels of plasma DLF in 13.4% of the youths, 17.2% of the normotensive adults, and 25.5% of the hypertensive adults. In all three groups of individuals, those with a measurable DLF had a significantly lower erythrocyte ouabain sensitive sodium efflux rate constant (adjusted for age, sex and body mass) than those with no measurable DLF (p < 0.01). Normotensive and hypertensive adults with measurable DLF also had an increased erythrocyte intracellular sodium level. Either the number of ouabain binding sites and/or the apparent affinity for ouabain were reduced for those with DLF levels in all three groups. There was a small nonsignificant increase in blood pressure for the normotensive adults and youths with a measurable DLF. We conclude that plasma DLF is associated with reduced ouabain sensitive sodium transport and increased intracellular sodium concentration, possibly due to changes in the number of or the competition for the Na+ K+ ATPase sites.

Original languageEnglish
Pages (from-to)183-188
Number of pages6
JournalClinical Biochemistry
Volume21
Issue number3
DOIs
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Ouabain
Erythrocytes
Sodium
Plasmas
digoxin-like factors
Digitalis
Digoxin
Blood pressure
Nutrition
Metabolism
Adenosine Triphosphatases
Rate constants
Assays
Binding Sites
Diet
Blood Pressure

Keywords

  • hypertension
  • Na K ATPase
  • natriuretic hormone
  • ouabain binding sites
  • red cell sodium

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding. / Hunt, Steven; Wu, Lily L.; Stults, Barry M.; Williams, Roger R.

In: Clinical Biochemistry, Vol. 21, No. 3, 1988, p. 183-188.

Research output: Contribution to journalArticle

Hunt, Steven ; Wu, Lily L. ; Stults, Barry M. ; Williams, Roger R. / A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding. In: Clinical Biochemistry. 1988 ; Vol. 21, No. 3. pp. 183-188.
@article{13fa9840094f4a09871b5a02082ca1cb,
title = "A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding",
abstract = "To investigate what effects a circulating digoxin-like factor (DLF) might have on sodium metabolism, we examined data collected on 1,327 individuals screened in the Cardiovascular Genetics Clinic at the University of Utah. This sample included 639 unmedicated adults, 582 youths under age 18, and 106 medicated hypertensive individuals, all on an unrestricted diet when attending clinic. No individuals took digitalis. A digoxin assay detected measurable levels of plasma DLF in 13.4{\%} of the youths, 17.2{\%} of the normotensive adults, and 25.5{\%} of the hypertensive adults. In all three groups of individuals, those with a measurable DLF had a significantly lower erythrocyte ouabain sensitive sodium efflux rate constant (adjusted for age, sex and body mass) than those with no measurable DLF (p < 0.01). Normotensive and hypertensive adults with measurable DLF also had an increased erythrocyte intracellular sodium level. Either the number of ouabain binding sites and/or the apparent affinity for ouabain were reduced for those with DLF levels in all three groups. There was a small nonsignificant increase in blood pressure for the normotensive adults and youths with a measurable DLF. We conclude that plasma DLF is associated with reduced ouabain sensitive sodium transport and increased intracellular sodium concentration, possibly due to changes in the number of or the competition for the Na+ K+ ATPase sites.",
keywords = "hypertension, Na K ATPase, natriuretic hormone, ouabain binding sites, red cell sodium",
author = "Steven Hunt and Wu, {Lily L.} and Stults, {Barry M.} and Williams, {Roger R.}",
year = "1988",
doi = "10.1016/0009-9120(88)90008-2",
language = "English",
volume = "21",
pages = "183--188",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding

AU - Hunt, Steven

AU - Wu, Lily L.

AU - Stults, Barry M.

AU - Williams, Roger R.

PY - 1988

Y1 - 1988

N2 - To investigate what effects a circulating digoxin-like factor (DLF) might have on sodium metabolism, we examined data collected on 1,327 individuals screened in the Cardiovascular Genetics Clinic at the University of Utah. This sample included 639 unmedicated adults, 582 youths under age 18, and 106 medicated hypertensive individuals, all on an unrestricted diet when attending clinic. No individuals took digitalis. A digoxin assay detected measurable levels of plasma DLF in 13.4% of the youths, 17.2% of the normotensive adults, and 25.5% of the hypertensive adults. In all three groups of individuals, those with a measurable DLF had a significantly lower erythrocyte ouabain sensitive sodium efflux rate constant (adjusted for age, sex and body mass) than those with no measurable DLF (p < 0.01). Normotensive and hypertensive adults with measurable DLF also had an increased erythrocyte intracellular sodium level. Either the number of ouabain binding sites and/or the apparent affinity for ouabain were reduced for those with DLF levels in all three groups. There was a small nonsignificant increase in blood pressure for the normotensive adults and youths with a measurable DLF. We conclude that plasma DLF is associated with reduced ouabain sensitive sodium transport and increased intracellular sodium concentration, possibly due to changes in the number of or the competition for the Na+ K+ ATPase sites.

AB - To investigate what effects a circulating digoxin-like factor (DLF) might have on sodium metabolism, we examined data collected on 1,327 individuals screened in the Cardiovascular Genetics Clinic at the University of Utah. This sample included 639 unmedicated adults, 582 youths under age 18, and 106 medicated hypertensive individuals, all on an unrestricted diet when attending clinic. No individuals took digitalis. A digoxin assay detected measurable levels of plasma DLF in 13.4% of the youths, 17.2% of the normotensive adults, and 25.5% of the hypertensive adults. In all three groups of individuals, those with a measurable DLF had a significantly lower erythrocyte ouabain sensitive sodium efflux rate constant (adjusted for age, sex and body mass) than those with no measurable DLF (p < 0.01). Normotensive and hypertensive adults with measurable DLF also had an increased erythrocyte intracellular sodium level. Either the number of ouabain binding sites and/or the apparent affinity for ouabain were reduced for those with DLF levels in all three groups. There was a small nonsignificant increase in blood pressure for the normotensive adults and youths with a measurable DLF. We conclude that plasma DLF is associated with reduced ouabain sensitive sodium transport and increased intracellular sodium concentration, possibly due to changes in the number of or the competition for the Na+ K+ ATPase sites.

KW - hypertension

KW - Na K ATPase

KW - natriuretic hormone

KW - ouabain binding sites

KW - red cell sodium

UR - http://www.scopus.com/inward/record.url?scp=0023764229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023764229&partnerID=8YFLogxK

U2 - 10.1016/0009-9120(88)90008-2

DO - 10.1016/0009-9120(88)90008-2

M3 - Article

C2 - 3390908

AN - SCOPUS:0023764229

VL - 21

SP - 183

EP - 188

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 3

ER -